TGFB1 and glioma: Short-chain fatty acids can also reduce the expression levels of IL-10 and TGF-β, and then improve the glioma TIME by promoting the proliferation of lymphocytes and the differentiation of T cells, as well as increasing the proportion of M1-type TAMs in the TME, thereby improving the prognosis of glioma patients (76).